Catalyst Wire Dossier Catalyst Wire Dossier

Growth factor agents combination

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Growth factor agents combination, covering 2025-02-06 to 2025-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes [Phase 3]

See pricing